Charlottesville, VA, United States of America

Siva Sai Krishna Dasa

This inventor holds 2 USPTO granted patents. Top assignee: University of Virginia Patent Foundation. Active years: 2022-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Siva Sai Krishna Dasa. Retrieved from https://idiyas.com/inventor/siva-sai-krishna-dasa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.7

ph-index = 1


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Siva Sai Krishna Dasa: Innovator in Cancer Treatment and Cardiovascular Disease

Introduction

Siva Sai Krishna Dasa is a prominent inventor based in Charlottesville, VA (US). He has made significant contributions to the fields of cancer treatment and cardiovascular disease through his innovative research and patented inventions. With a total of 2 patents, Dasa is recognized for his dedication to advancing medical science.

Latest Patents

Dasa's latest patents include "Plectin-targeted liposomes/PARP inhibitor in the treatment of cancer," which provides compositions and methods to treat cancer effectively. Another notable patent is "Target-specific delivery of therapeutic agents," which describes isolated peptides targeting cardiovascular disease and methods for delivering therapeutic payloads to specific cell types or tissues.

Career Highlights

Siva Sai Krishna Dasa is affiliated with the University of Virginia, where he conducts his research and develops his innovative solutions. His work focuses on creating targeted therapies that can improve patient outcomes in critical health areas.

Collaborations

Dasa collaborates with esteemed colleagues, including Kimberly A Kelly and Alexander L Klibanov, to enhance the impact of his research and inventions.

Conclusion

Siva Sai Krishna Dasa is a dedicated inventor whose work in cancer treatment and cardiovascular disease showcases the potential of targeted therapies. His contributions to medical science are paving the way for innovative solutions that can significantly improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…